BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,975 | -20.3% | 0.00% | – |
| Q2 2023 | $5,000 | 0.0% | 2,478 | +61.6% | 0.00% | – |
| Q1 2023 | $5,000 | +66.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2022 | $3,000 | -57.1% | 1,533 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 1,533 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,533 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 1,533 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | +20.0% | 1,533 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 1,533 | -18.1% | 0.00% | – |
| Q2 2021 | $7,000 | -81.1% | 1,872 | -80.2% | 0.00% | – |
| Q1 2021 | $37,000 | -32.7% | 9,436 | -21.3% | 0.00% | – |
| Q4 2020 | $55,000 | -71.1% | 11,988 | +6.7% | 0.00% | – |
| Q3 2020 | $190,000 | +31.0% | 11,231 | -13.1% | 0.00% | – |
| Q2 2020 | $145,000 | +145.8% | 12,931 | +1.5% | 0.00% | – |
| Q1 2020 | $59,000 | +40.5% | 12,741 | +30.1% | 0.00% | – |
| Q4 2019 | $42,000 | +7.7% | 9,796 | -3.4% | 0.00% | – |
| Q3 2019 | $39,000 | 0.0% | 10,143 | +3.5% | 0.00% | – |
| Q2 2019 | $39,000 | -7.1% | 9,796 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | +23.5% | 9,796 | +2.8% | 0.00% | – |
| Q4 2018 | $34,000 | -5.6% | 9,533 | -0.4% | 0.00% | – |
| Q3 2018 | $36,000 | -2.7% | 9,575 | +0.4% | 0.00% | – |
| Q2 2018 | $37,000 | +23.3% | 9,533 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +66.7% | 9,533 | +110.3% | 0.00% | – |
| Q4 2017 | $18,000 | 0.0% | 4,533 | -0.2% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 4,544 | +12.7% | 0.00% | – |
| Q2 2017 | $17,000 | 0.0% | 4,033 | 0.0% | 0.00% | – |
| Q1 2017 | $17,000 | +183.3% | 4,033 | +59.2% | 0.00% | – |
| Q4 2016 | $6,000 | -78.6% | 2,533 | -78.0% | 0.00% | – |
| Q3 2016 | $28,000 | 0.0% | 11,533 | 0.0% | 0.00% | – |
| Q2 2016 | $28,000 | -6.7% | 11,533 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | +3.4% | 11,533 | +15.0% | 0.00% | – |
| Q4 2015 | $29,000 | +81.2% | 10,033 | +42.7% | 0.00% | – |
| Q3 2015 | $16,000 | +300.0% | 7,033 | +580.8% | 0.00% | – |
| Q2 2015 | $4,000 | 0.0% | 1,033 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 1,033 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | +150.0% | 1,033 | +93.8% | 0.00% | – |
| Q3 2014 | $2,000 | – | 533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
| EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
| Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
| CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
| HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
| Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |